2nd Quarter - Report

OTSUKA AMERICA PHARMACEUTICAL, INC. for OTSUKA AMERICA PHARMACEUTICAL, INC.

Firm
Client
Income
—
Expenses
$630,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Supply Chain,Drug Pricing (H.R.3, SFC bill PDPRA), Medicare Part D Redesign, Renal Care Policy, Mental Health Policy Issues

LobbyistCovered position, as disclosed
THADDEUS FLOOD New —
ORKIDEH MALKOC —
MOLLY RYAN —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3 (116th)

Health Issues HCR

Kidney Health, Mental Health

LobbyistCovered position, as disclosed
THADDEUS FLOOD —
ORKIDEH MALKOC —
MOLLY RYAN —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.